正在為您準備內容...
正在為您準備內容...
成份 · Ingredient
硼替佐米
硼替佐米是一種可逆性蛋白酶體抑制劑，屬於二肽基硼酸類化合物。它通過抑制26S蛋白酶體的活性來阻止癌細胞生長，主要用於治療多發性骨髓瘤和套細胞淋巴瘤等血液惡性腫瘤。
Bortezomib is L-Phenylalaninamide substituted at the amide nitrogen by a 1-(dihydroxyboranyl)-3-methylbutyl group and at Nalpha by a pyrazin-2-ylcarbonyl group. It is a dipeptidyl boronic acid that reversibly inhibits the 26S proteasome. It has a role as an antineoplastic agent, an antiprotozoal drug, a protease inhibitor and a proteasome inhibitor. It is an amino acid amide, a member of pyrazines and a L-phenylalanine derivative. It is functionally related to a boronic acid.
藥品資料來源：香港衞生署藥物辦公室 · 化學資料來源：PubChem (NIH) · 資料僅供參考，不構成醫療建議